Pulmonary embolism after transcatheter arterial chemoembolization.
Metastatic hepatic tumours can be treated with hepatic transcatheter arterial chemoembolization (TACE). Common complications associated with TACE include hepatic insufficiency, fever, and pain. However, pulmonary embolism is rarely documented as a fatal adverse effect. We report a case of pulmonary embolism following TACE in a renal cell carcinoma patient with liver metastases. Total recovery is noted after the effective treatment.
Shiah
H-S
HS
Division of Cancer Research, National Health Research Institutes, Taipei, Taiwan. hsshiah@nhri.org.tw
Liu
T-W
TW
Chen
L-T
LT
Chang
J-Y
JY
Liu
J M
JM
Chuang
T-R
TR
Lee
W-S
WS
Whang-Peng
J
J
D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D002404:Catheterization; D016461:Chemoembolization, Therapeutic / Q000009:adverse effects*; D006499:Hepatic Artery; D006801:Humans; D008113:Liver Neoplasms / Q000628:therapy*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D011655:Pulmonary Embolism / Q000209:etiology* / Q000628:therapy; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D008775:Methylprednisolone